Blockade of Airway Inflammation by Kaempferol via Disturbing Tyk-STAT Signaling in Airway Epithelial Cells and in Asthmatic Mice by Ju-Hyun Gong et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 250725, 13 pages
http://dx.doi.org/10.1155/2013/250725
Research Article
Blockade of Airway Inflammation by Kaempferol
via Disturbing Tyk-STAT Signaling in Airway Epithelial
Cells and in Asthmatic Mice
Ju-Hyun Gong, Daekeun Shin, Seon-Young Han, Sin-Hye Park, Min-Kyung Kang,
Jung-Lye Kim, and Young-Hee Kang
Department of Food and Nutrition, Hallym University, Chuncheon, Gangwon-do 200-702, Republic of Korea
Correspondence should be addressed to Young-Hee Kang; yhkang@hallym.ac.kr
Received 10 December 2012; Revised 28 March 2013; Accepted 15 April 2013
Academic Editor: Seung-Heon Hong
Copyright © 2013 Ju-Hyun Gong et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Asthmaischaracterizedbybronchialinflammationcausingincreasedairwayhyperresponsivenessandeosinophilia.Theinteraction
betweenairwayepitheliumandinflammatorymediatorsplaysakeyroleintheasthmaticpathogenesis.Theinvitrostudyelucidated
inhibitory effects of kaempferol, a flavonoid found in apples and many berries, on inflammation in human airway epithelial
BEAS-2B cells. Nontoxic kaempferol at ≤20𝜇M suppressed the LPS-induced IL-8 production through the TLR4 activation,
inhibiting eotaxin-1 induction. The in vivo study explored the demoting effects of kaempferol on asthmatic inflammation in
BALB/c mice sensitized with ovalbumin (OVA). Mouse macrophage inflammatory protein-2 production and CXCR2 expression
were upregulated in OVA-challenged mice, which was attenuated by oral administration of ≥10mg/kg kaempferol. Kaempferol
allayed the airway tissue levels of eotaxin-1 and eotaxin receptor CCR3 enhanced by OVA challenge. This study further explored
theblockadeofTyk-STATsignalingbykaempferolinbothLPS-stimulatedBEAS-2BcellsandOVA-challengedmice.LPSactivated
Tyk2 responsible for eotaxin-1 induction, while kaempferol dose-dependently inhibited LPS- or IL-8-inflamed Tyk2 activation.
Similar inhibition of Tyk2 activation by kaempferol was observed in OVA-induced mice. Additionally, LPS stimulated the
activation of STAT1/3 signaling concomitant with downregulated expression of Tyk-inhibiting SOCS3. In contrast, kaempferol
encumbered STAT1/3 signaling with restoration of SOCS3 expression. Consistently, oral administration of kaempferol blocked
STAT3 transactivation elevated by OVA challenge. These results demonstrate that kaempferol alleviated airway inflammation
through modulating Tyk2-STAT1/3 signaling responsive to IL-8 in endotoxin-exposed airway epithelium and in asthmatic mice.
Therefore, kaempferol may be a therapeutic agent targeting asthmatic diseases.
1. Introduction
Allergic asthma is characterized by the infiltration of eosino-
phils, mast cells, and T-lymphocytes into airway epithelium
[1, 2]. This infiltration usually leads to bronchial epithelial
layer desquamation, goblet cell hyperplasia, and submucosa
thickening [3]. The interplay between airway epithelial cells
and the immune cells plays an important role in the patho-
genesis of an allergic asthma attack [4]. Accordingly, the air-
way epithelium is both a target of inflammatory and physical
insults and an effecter of ongoing airway inflammation. In
asthmatic process, antigen-sensitized T helper 2 (Th2) cells
produce specific cytokines, which cause several key features
of allergic bronchial asthma [5]. Both IL-4 and IL-13 may
stimulate epithelial cells to produce chemokines such as
eotaxin and growth factors [6]. The eosinophil attachment
and infiltration into the airway epithelium entail binding of
eotaxin to C-C chemokine receptor type 3 (CCR3) expressed
on eosinophils [2]. Proinflammatory IL-8 is secreted by
macrophages and lung epithelial cell into lung fluid and
recruits neutrophils and eosinophils to the sites of inflam-
mation [7]. Accordingly, the IL-8 overexpression in human
b r o n c h i a le p i t h e l i a lc e l l sm a yp l a yap i v o t a lr o l ei nt h e
eosinophil infiltration into inflamed airways [8].
Exposuretolipopolysaccharide(LPS)increasesthesever-
ity of asthma, which activates Toll-like receptor (TLR) sig-
nalingintheregulationofTh2-drivenlunginflammation[9].
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promotesinflammatorymechanismsincludingnuclearfactor
(NF)-𝜅B and Janus-activated kinase (JAK)/signal transduc-
ers and activators of transcription (STAT) pathways [10].
Cytokine stimulation activates the STAT pathway via phos-
phorylation of tyrosine residues by receptor-associated JAK
family members [11]. Thus, the regulation of IL-8 response
in airway epithelial cells through the inflammatory signaling
pathwaypreventsexplosiveinflammatoryreactions.Thesup-
pressors of cytokine signaling (SOCS) have emerged as the
physiologicalorpathologicalregulatorsofcytokineresponses
in the inflammatory systems [12]. The SOCS proteins have
important mechanism for the negative regulation of the
cytokine-STAT pathway [13]. STAT6 is important in the
regulation of lung inflammation in response to allergens and
viruses in murine models with asthma [14]. However, much
less is known about the role of STAT1/3 in mediating allergic
responses in asthma.
Kaempferol is a natural flavonol-type flavonoid that has
been isolated from plant sources. Kaempferol effectively
suppresses the development of IgE-mediated allergic inflam-
mation of intestinal cell models by inhibiting the secretion
of allergic mediators [15]. The flavonol fisetin ameliorates
asthmatic phenotypes, which is associated with reduction
of Th2 responses as well as suppression of NF-𝜅Ba n di t s
downstream chemokines [16]. Quercetin and kaempferol
inhibited IgE-mediated release of proinflammatory media-
tors from human mast cells, which may be due to inhibition
of intracellular calcium influx and PKC𝜃 signaling [17].
Recently, we have demonstrated that kaempferol suppresses
eosinophil infiltration and airway inflammation in allergic
asthma [18]. It was also found that kaempferol attenuated
airwayallergicresponsesthroughdisturbingNF-𝜅Bsignaling
andeotaxin-1secretion.However,themolecularmechanisms
underlying the antiallergic actions of kaempferol should be
fully clarified.
Based on the literature evidence that kaempferol pos-
sessesanti-inflammatoryandantiallergicactivities,thisstudy
investigated whether kaempferol inhibited inflammation in
LPS-induced airway epithelial BEAS-2B cells through block-
ing TLR4 activation. It was tested that IL-8 was respon-
sible for LPS-stimulated eotaxin-1 induction in epithelial
cells. Furthermore, the suppressive effects of kaempferol
on airway inflammation were evaluated in OVA-challenged
BALB/c mice by measuring macrophage inflammatory pro-
tein (MIP)-2, CCR3, and eotaxin-1. This study elucidated
whether kaempferol encumbered Tyk-STAT signaling path-
way responsive to LPS and OVA in airway inflammation and
eosinophilia.
2. Materials and Methods
2.1. Chemicals. M199, human epidermal growth factor
(EGF), hydrocortisone, gelatin, human insulin, apotransfer-
rin, LPS, and albumin from chicken egg white were obtained
from the Sigma-Aldrich Chemical (St. Louis, MO, USA), as
were all other reagents, unless specifically stated elsewhere.
Fetal bovine serum (FBS), penicillin-streptomycin, and
trypsin-EDTA were purchased from the Lonza (Walkersville,
MD, USA). Human bronchial airway epithelial cell line,
BEAS-2B, was provided by the American Type Culture Col-
lection (ATCC, Manassas, VA, USA). Imject Alum (aqueous
solution of 40mg/mL aluminum hydroxide and 40mg/mL
magnesium hydroxide plus inactive stabilizers) was pur-
chased from Thermo Fisher Scientific (Rockford, IL, USA).
For western blot analysis and immunohistochemical assay,
antibodies against human phospho-Tyk2, human phospho-
STAT1/3, STAT3, and mouse phospho-STAT3 were obtained
from Cell Signaling Technology (Beverly, MA, USA). Anti-
human eotaxin-1 and antihuman IL-8 were purchased from
R&D Systems (Minneapolis, MN, USA). Antihuman TLR4,
antimouse CCR3, and antihuman SOCS3 were purchased
from the Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Human Tyk2 inhibitor was provided by Calbiochem (Darm-
stadt, Germany). Horseradish peroxidase-conjugated goat
antirabbit IgG, donkey antigoat IgG, and goat antimouse
IgG were acquired from Jackson Immunoresearch Labora-
tories (West Grove, PA, USA). Albumin from bovine serum
(essentiallyfattyacidfree)andskimmilkwereacquiredfrom
Becton Dickinson Company (Sparks, MD, USA). Enzyme-
linked immunosorbent assay (ELISA) kits of human IL-8,
mouse MIP-2, and mouse eotaxin-1 were purchased from
R&D Systems.
2.2. BEAS-2B Cell Culture and Viability. BEAS-2B cells were
cultured in 25mM HEPES-buffered M199 containing 10%
FBS, 2mM glutamine,100U/mL penicillin,100𝜇g/mL strep-
tomycin supplemented with 2.5𝜇g/mL insulin, 0.361𝜇g/mL
hydrocortisone, 2.5𝜇g/mL apotransferrin, and 20ng/mL
human EGF. The 90–95% confluence of BEAS-2B cells was
sustained at 37
∘Ci na na t m o s p h e r eo f5 %C O 2 during
cell experiments. Kaempferol at 1–20𝜇Mw a sp r e t r e a t e d
overnight, and then LPS or IL-8 applied to BEAS-2B cells
to induce eotaxin-1, phospho-STAT1, and phospho-STAT3.
A peak expression of eotaxin-1 was attained when LPS was
added to BEAS-2B cells for 8h [18].
The cytotoxicity of ≤20𝜇M kaempferol was determined
after 48h culture of BEAS-2B cells using an MTT (3-(4,5-
dimethylthiazol-yl)-diphenyl tetrazolium bromide, Duchefa
Biochemie, Haarlem, The Netherlands) assay. Briefly, cells
were maintainedin a fresh medium including 1mg/mL MTT
at 37
∘Cf o r3 h .G e n t l es h a k i n gw a sc o n d u c t e dt od i s s o l v e
purple formazan product in 0.5mL isopropanol, and the
absorbance of formazan was determined at 𝜆 =5 7 0 n m
usingamicroplatereader(Bio-RadModel550,Hercules,CA,
USA).
2.3. Induction of Airway Inflammation in a Murine Model.
Six-week-old male BALB/c mice (Hallym University Breed-
ing Center for Laboratory Animals) were kept on a 12h
light/12hdarkcycleat23±1
∘Cwith50±10%relativehumid-
ity under specific pathogen-free conditions. Mice were fed
a nonpurified diet (RodFeedTM, DBL, Umsung, Korea) and
were provided with water ad libitum at the Animal Facility
of Hallym University. The nonpurified diet composition was
as follows: not less than (NLT) 20.5% crude protein, NLT
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NMT 8.0% crude ash, NLT 0.5% calcium, and NLT 0.5%
p h o s p h o r u s .M i c ew e r ea l l o w e dt oa c c l i m a t i z ef o r1w e e k
before beginning the experiments. Mice were divided into
four subgroups (𝑛=6 for each subgroup). Mice were
sensitized with 20𝜇gO V Ad i s s o l v e di nas o l u t i o no f3 0𝜇L
PBS and 50𝜇LI m j e c tA l u mb ys u b c u t a n e o u si n j e c t i o nt w i c e
on day 0 and day 14. Kaempferol solution (0.1mL, 10 or
20mg/kg BW) was orally administrated to OVA-sensitized
mice 1h before OVA challenge. On day 28, day 29, and
day 30, the 5% OVA inhalation to mice was performed
for 20min in a plastic chamber linked to an ultrasonic
nebulizer (Clenny
2 Aerosol, Medel, S. Polo di Torrile, Italy).
C o n t r o lm i c ew e r es e n s i t i z e da n dc h a l l e n g e dw i t hP B Sa s
the OVA vehicle. All mice were sacrificed with an anes-
thetic (2𝜇L/kg Rompun and 8𝜇L/kg Zoletil, intraperitoneal
injection) 24h after the last challenge (day 30). The right
lungs were collected, frozen to liquid nitrogen, and kept at
−80
∘C for the extraction, and the left lungs were preserved
and fixed in 4% paraformaldehyde and then used for the
staining.
AllexperimentswereapprovedbytheCommitteeonAni-
malExperimentationofHallymUniversityandperformedin
compliance with the University’s Guidelines for the Care and
Use of Laboratory Animals (Hallym 2010-66). No mice were
dead, and no apparent signs of exhaustion were observed
during the experimental period.
2.4. Western Blot Analysis. Whole BEAS-2B cell lysates or
BALB/c lung tissue extracts were prepared in 1M Tris-HCl
(pH 6.8) lysis buffer containing 10% SDS, 1% glycerophos-
phate, 0.1M Na3VO4, 0.5M NaF, and protease inhibitor
cocktail. Equal volumes of cell culture supernatants and
equal amounts of cell lysates or tissue extracts proteins were
electrophoresed on 8–15% SDS-PAGE gel and transferred
onto a nitrocellulose membrane. Blocking of nonspecific
binding was performed in a TBS-T buffer (50mM Tris-
HCl (pH 7.5), 150mM NaCl, and 0.1% Tween 20) contain-
ing either 3% bovine serum albumin or 5% nonfat dry
milk for 3h. The membrane was incubated overnight at
4
∘Cw i t has p e c i fi cp r i m a r ya n t i b o d y .A ft e rt r i p l ew a s h -
ing with TBS-T buffer, the membrane was then applied
to a goat antirabbit IgG, donkey antigoat IgG, or goat
antimouse IgG conjugated to horseradish peroxidase for
1h. Following another triple washing, target protein was
determined using the SuperSignal West Pico Chemilumi-
nescence detection reagents (Pierce Biotechnology, Rock-
ford, IL, USA) and the Agfa medical X-ray film blue
(Agfa HealthCare NV, Mortsel, Belgium). Antihuman 𝗽-
actin incubation was accomplished for the comparative
control.
2.5. Reverse Transcriptase-Polymerase Chain Reaction (RT-
PCR) Analysis. F o l l o w i n gc u l t u r ep r o t o c o l s ,t o t a lR N Aw a s
isolated from LPS-treated BEAS-2B cells using a commer-
cially available Trizol reagent kit (Invitrogen, Carlsbad, CA,
USA). The RNA (5𝜇g) was reversibly transcribed with 200
units of reverse transcriptase and 0.5mg/mL oligo-(dT)15
primer (Bioneer, Daejeon, Republic of Korea). The expres-
s i o n so ft h em R N At r a n s c r i p t so fT L R 4( f o r w a r dp r i m e r
5
򸀠-CAT TGG TGT GTC GGT CCT CA-3
򸀠, reverse primer
5
򸀠-ACT GCC AGG TCT GAG CAA TC-3
򸀠,3 7 7b p )a n d𝗽-
actin(forwardprimer5
򸀠-GACTACCTCATGAAGATC-3
򸀠,
reverseprimer5
򸀠-GAT CCA CAT CTG CTG GAA-3
򸀠,512bp)
wereevaluatedbyRT-PCR.ThePCRwasperformedin25𝜇L
buffer (10mM Tris-HCl (pH 9.0), 25mM MgCl2,1 0 m M
d N T P ,5u n i t so fT a qD N Ap o l y m e r a s e ,a n d1 0𝜇M of each
primer) and terminated by heating at 94
∘Cf o r1 0m i n .A ft e r
thermocycling and electrophoresis of 25𝜇LP C Rp r o d u c t s
on 1.5% agarose-formaldehyde gel, the bands were visual-
ized using a TFX-20M model-UV transilluminator (Vilber-
Lourmat,Marne-la-Vall´ ee,France),andgelphotographswere
obtained.Theabsenceofcontaminantswasroutinelychecked
by the RT-PCR assay of negative control samples without a
primer addition.
2.6. ELISA. Cell-free culture media were collected from
BEAS-2B cells and stored at −20
∘C. IL-8 secretion and tissue
levels of MIP-2 and eotaxin-1 were examined in culture
media or BALB/c lung tissue extracts by using each ELISA
kit (Microplate Reader, Molecular Devices, Sunnyvale, CA,
USA).
2.7. Lung Immunohistochemistry. Immunohistochemical
analysis was carried out by using antibodies against mouse
CXCR2, mouse phospho-Tyk2, and phospho-STAT3. All
lung tissue sections were subjected to a series of immuno-
histochemicalproceduresincludingtheAgretrievalfollowed
by quenching of endogenous peroxidase activity. For the
measurement of tissue levels of CXCR2 and phospho-Tyk2,
animmunofluorescenthistochemicalanalysiswasconducted
using antimouse CXCR2 or antimouse phospho-Tyk2 and
Cy3- or FITC-conjugated antigoat IgG. Nuclear staining
was done with 4
򸀠,6-diamidino-2-phenylindole (DAPI). For
the detection of phospho-STAT3, 3,3
򸀠-diaminobenzidine
chromogenic substrate detection kit (Dako, Carpinteria,
CA, USA) was used. Counter staining was conducted
with hematoxylin. Each slide was mounted in VectaMount
mounting medium (Vector Laboratories, Burlingame, CA,
USA). Images of each slide were taken using an optical
microscope system (Axiomager, Zeiss, Germany). Protein
levels of CXCR2, phospho-Tyk2, and phospho-STAT3 were
quantified by the image analysis program of the microscope
system.
2.8. Statistical Analysis. The data are presented as mean ±
SEM for each treatment group in the in vivo and in vitro
experiments. Statistical analyses were conducted using a Sta-
tistical Analysis Systems program (SAS Institute, Cary, NC,
USA). One-way ANOVA was used to determine inhibitory
effects of kaempferol on airway inflammation and allergic
responses in epithelial cells and sensitized mice. Differences
among treatment groups were analyzed with Duncan’s mul-
tiple range test and were considered to be significant at 𝑃<
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3. Result
3.1. Suppression of LPS-Promoted TLR4 Induction and IL-8
Production by Kaempferol. Mammalian TLR4 is the signal-
transducing receptor activated by the bacterial LPS and
lipotechoic acid [10, 19]. Western blot analysis showed that
TLR4 served as an epithelial receptor to LPS for the airway
inflammatoryprocess.HumanBEAS-2Bcellswereincubated
with 2𝜇g/mL LPS in the absence and presence of 1–20𝜇M
kaempferol for 8h. The expression of TLR4 was greatly
elevated in LPS-stimulated BEAS-2B cells (Figure 1(a)). This
study investigated whether 1–20𝜇M kaempferol inhibited
the induction of TLR4 triggered by LPS. When BEAS-2B
cells were incubated with ≤20𝜇M kaempferol for 24h, there
was no notable cytotoxicity observed [18]. When nontoxic
kaempferol was added, the TLR4 induction was inhibited
in a dose-dependent manner. Additionally, kaempferol sup-
pressed the expression of TLR4 mRNA (Figure 1(b)).
This study elucidated that LPS induced cellular expres-
sion of IL-8 through stimulating TLR4 signaling and that
kaempferol encumbered IL-8 induction. LPS enhanced cel-
lular secretion of IL-8, which was dampened by the nontoxic
TLR inhibitor OxPAPC at 20𝜇g/mL (Figure 1(c)). Similar
inhibition was observed with 20𝜇M kaempferol. In addi-
tion, LPS increased the IL-8 secretion of BEAS-2B cells
(Figure 1(d)). However, the treatment of LPS-exposed cells
with ≥1𝜇M kaempferol markedly attenuated such secretion.
The current study attempted to prove that IL-8 is one of
the pivotal factors responsible for asthmatic airway inflam-
mation. Chemokines with protein sequence homology to
h u m a nI L - 8h a v en o tb e e ni d e n t i fi e di nm i c e[ 20]. The CXC
chemokines KC and MIP-2 (also known as CXCL2) are
functional homologs of human IL-8 in mice. Accordingly,
the MIP-2 levels in mouse lung tissue were measured. OVA
challenge increased MIP-2 production in mouse lung tissue
(Figure 2(a)). However, kaempferol supplemented to OVA-
challenged mice markedly diminished MIP-2 production.
Furthermore, this study examined the induction of CXCR2,
the receptor to IL-8, in lung tissues of OVA-challenged mice.
Therewaslackofcytoplasmicstaininginthenegativecontrol
mice (Figure 2(b)). However, a strong cytoplasmic reddish
staining was observed in OVA-challenged mice. In contrast,
the CXCR2 induction was dose dependently attenuated in
mice supplemented with kaempferol (Figure 2(c)).
3.2. Attenuation of LPS-Induced Eotaxin-1 Expression by
Kaempferol. This study investigated whether IL-8 was in-
volved in the eosinophil infiltration by inducing eotaxin-
1 protein in endotoxin-experienced airway epithelial cells.
Eotaxin-1expressionwasgreatlyenhancedinIL-8-stimulated
BEAS-2B cells, which was reversed by treating ≥10𝜇M
kaempferol (Figure 3(a)). Accordingly, the suppression of IL-
8 production by kaempferol may be associated with its block-
ade of early airway inflammation. Additionally, 20𝜇g/mL
OxPAPC abolished the induction of eotaxin-1 protein in
LPS-exposed BEAS-2B cells (Figure 3(b)), indicating that
its induction by LPS was mediated via the TLR4 signaling
encumbered by kaempferol.
The role of eotaxin-1 in the airway inflammation was
verified in lung tissues of OVA-challenged mice. CCR3 can
serve as a receptor for several different chemokines such as
macrophage inflammatory proteins, monocyte chemoattrac-
tant proteins, and eotaxins.
Most of the ligands to CCR3 are associated with asthma,
and CCR3 has become an appealing possibility in asthma
treatment or therapy [21]. The lung tissue level of CCR3 was
enhanced in OVA-exposed mice (Figure 3(c)). In contrast,
the supplementation of kaempferol abrogated the CCR3
protein level at the kaempferol-given dosages of 10 and
20mg/kg. Additionally, this study determined the eotaxin-
1 production in lung tissues of OVA-challenged mice. OVA
elevated the eotaxin-1 protein level in mouse lung tissues
(Figure 3(d)). However, in OVA-experienced mice supple-
mented with kaempferol, the eotaxin-1 production was dose
dependently diminished.
3.3. Inhibitory Effect of Kaempferol on Tyk2-STAT Activa-
tion. Activation of TLR4 by LPS leads to promotion of
theinflammatorymechanismsincludingJNK/SAPK,NF-𝜅B,
and JAK/STAT pathways [10]. This study elucidated whether
Tykdownstreamsignalingwasresponsibleforairwayinflam-
mation induced by LPS. BEAS-2B cells were incubated with
2𝜇g/mL LPS, and Tyk2 activation was determined based on
2–6hintervalupto24h.Tyk2phosphorylationwasgradually
elevatedupto8–12handthereafterdiminished(Figure 4(a)).
When kaempferol was added to LPS-exposed BEAS-2B cells,
the Tyk2 activation was suppressed in a dose-dependent
manner (Figure 4(b)). Similar effects on Tyk activation were
observed with IL-8 (Figure 4(c)).
This study further tested whether the eotaxin-1 induction
through TLR4 signaling by both LPS and IL-8 entailed
Tyk2 activation. The Tyk inhibitor at 20𝜇Ms u p p r e s s e dt h e
eotaxin-1 induction in IL-8-stimulated BEAS-2B cells in a
similar manner to 20𝜇M kaempferol (Figure 5(a)). Likewise,
phosphorylated Tyk2 was notably observed in peribronchial
regions of OVA-exposed mouse lung tissues, evidenced
by immunofluorescent FITC tissue staining (Figure 5(b)).
However, the FITC green fluorescence disappeared in lung
tissues by supplying kaempferol to OVA-challenged mice at
the dosages of 10 and 20mg/kg (Figure 5(c)), indicating that
kaempferoldiminishedairwayinflammationbydeterringthe
Tyk2 activation.
3.4. Disturbance of STAT3 Transactivation by Kaempferol.
Next, this study examined whether the phosphorylation
of STAT1 and STAT3, the Tyk downstream effectors, was
promoted by LPS in BEAS-2B cells. The phosphorylation
of both STAT1 and STAT3 peaked at 8h and stayed up in
LPS-exposed BEAS-2B cells (Figure 6(a)). When BEAS-2B
cells were activated by 2𝜇g/mL LPS, ≥10𝜇M kaempferol
significantly suppressed the phosphorylation of STAT1 and
STAT3, resulting in an increase in unphosphorylated STAT3
(Figure 6(b)). Thus, kaempferol may be an antagonist to this
induction of STAT1/3 signaling in response to LPS in BEAS-
2B cells. This implies that LPS promoted Tyk2 activation andEvidence-Based Complementary and Alternative Medicine 5
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Figure 1: Inhibitory effects of kaempferol on expression levels (a) and transcription (b) of TLR4 and blockade of IL-8 secretion by TLR4
inhibition (c) and IL-8 secretion (d) in LPS-stimulated BEAS-2B cells. After culturing cells with2𝜇g/mL LPS in the absence and presence of
1–20 𝜇M kaempferol or 20𝜇g/mL OxPAPC for 8h, cell extracts were subjected to 8% SDS-PAGE and western blot analysis with a primary
antibody against TLR4 and IL-8. Representative blot data were obtained from 3 experiments, and 𝗽-actin protein was used as an internal
control.ThemRNAlevelsofTLR4wereanalyzedbyusingRT-PCR(b).𝗽-actinwasusedasahousekeepinggeneforthecoamplification with
TLR4. The bar graphs (mean ± SEM) in the bottom panels represent quantitative results of blots. Cell culture media were collected for the
measurement of IL-8 secretion by using an ELISA kit (d). Values not sharing a common letter are significantly different at 𝑃 < 0.05.
sequentially activated STAT1/3 signaling leading to airway
inflammation.
SOCS family members are cytokine-inducible negative
regulators of cytokine signaling. The expression of SOCS3,
the protein binding to Tyk2/JAK2 and inhibiting their
activity, was dampened in LPS-experienced BEAS-2B cells
(Figure 6(c)).ThisresultprovedthatLPSpositivelyregulated
STAT signaling pathway, while kaempferol disturbed this
pathway by restoring the SOCS3 expression in an opposite
fashion.Accordingly,kaempferolmaybluntIL-8signalingby
enhancing the inhibitory function of SOCS3 targeting Tyk2
activity.6 Evidence-Based Complementary and Alternative Medicine
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was identified as red staining and quantified by using an optical microscope system (c). Each photograph was representative of four mice.
Magnification: 200-fold. Values in the bar graphs (mean ± SEM) not sharing a common letter are significantly different at 𝑃 < 0.05.
Consistent with LPS-induced STAT3 activation in air-
way epithelial cells, the OVA challenge increased nuclear
translocation of STAT3, manifested as brown nuclear stain-
ing. There was a significant increase in the numbers of
dark brown-stained nuclear STAT3 observed (Figure 7(a)),
demonstrating that the OVA incitement inflamed nuclear
activation of STAT3. In contrast, the OVA-promoted STAT3
transactivation diminished in kaempferol-delivered mice
(Figure 7(b)). Therefore, the specific blockade of Tyk-STAT
in the airway/lung of sensitized mice by oral administration
of kaempferol may be a useful anti-inflammatory strategy to
confer asthmatic protection.
4. Discussion
Inflammatory and allergic asthma is characterized by the
infiltration of eosinophils, mast cells, and T lymphocytes
into airway epithelium [1, 2]. The interplay between theseEvidence-Based Complementary and Alternative Medicine 7
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Figure 3: Western blot data showing inhibition of eotaxin-1 expression by kaempferol or OxPAPC in LPS- or IL-8-stimulated in BEAS-2B
cells (a and b). After culturing cells with 2𝜇g/mL LPS in the absence and presence of 1–20𝜇M kaempferol or 20𝜇g/mL OxPAPC for 8h,
cell extracts were subjected to 15% SDS-PAGE and western blot analysis with a primary antibody against eotaxin-1. 𝗽-actin protein was used
as an internal control. Inhibition of CCR3 expression and eotaxin-1 secretion by kaempferol in OVA-challenged mouse lung tissues (c and
d). Tissue extracts were subjected to western blot analysis with a primary antibody against murine CCR3 (c). The bar graphs (mean ± SEM,
𝑛=3 ) in the bottom panels represent quantitative results. Eotaxin-1 production was measured in OVA-challenged mouse lung tissues by
using an ELISA kit (d). Values in bar graphs not sharing a letter indicate significant difference at 𝑃 < 0.05.8 Evidence-Based Complementary and Alternative Medicine
Phospho-Tyk2        
𝗽-actin
0 2 4 6 8 12 18 24 (h)
2 𝜇g/mL LPS
140 kDa
42 kDa
(a)
P
h
o
s
p
h
o
-
T
y
k
2
 
(
f
o
l
d
 
o
f
 
c
o
n
t
r
o
l
)
 
0
1
2
3
4
b
c
d d
a
Phospho-Tyk2        
𝗽-actin
140 kDa
42 kDa
1 10 20
Untreated
control
Kaempferol (𝜇M)
2 𝜇g/mL LPS
(b)
a
a
b
c c
Phospho-Tyk2        
𝗽-actin
140 kDa
42 kDa
1 10 20
Untreated
control
Kaempferol (𝜇M)
P
h
o
s
p
h
o
-
T
y
k
2
 
(
f
o
l
d
 
o
f
 
c
o
n
t
r
o
l
)
 
0
1
2
3
4
10 ng/mL IL-8
(c)
Figure 4: Temporal activation of Tyk2 (a) and its blockade by kaempferol in LPS-exposed epithelial cells. BEAS-2B cells were cultured with
2𝜇g/mL LPS (b) or 10ng/mL IL-8 (c) in the absence and presence of 1–20𝜇M kaempferol for 8h. Total cell protein extracts were subjected to
western blot analysis with a primary antibody against phosphorylated Tyk2. 𝗽- a c t i nw a su s e da sa ni n t e r n a lc o n t r o l .Th eb a rg r a p h s( m e a n±
SEM, 𝑛=4 ) in the bottom panels represent quantitative densitometric results. Means without a common letter differ, 𝑃 < 0.05.
cells and airway epithelial cells plays an important role in
the pathogenesis of an asthmatic episode [4]. The specific
cytokines such as IL-4, IL-5, and IL-13 cause several key
features of allergic bronchial asthma [5]. In addition, the
eosinophilattachmentandinfiltrationintotheairwayepithe-
liumentailthebindingofeotaxinproteinstoCCR3expressed
on eosinophils, basophils, and Th2 cells [2]. The CXC
chemokine IL-8 is a proinflammatory mediator associated
withthechemotaxisanddegranulationofneutrophils,Tcells,
basophils,andeosinophils[7].Itisproducedbymacrophages
and lung epithelial cells into lung fluid and recruits neu-
trophilsandeosinophilstothesitesofinflammation.Accord-
ingly, the overexpression of IL-8 in human bronchial epithe-
lialcellsplaysapivotalroleintherecruitmentandinfiltration
of eosinophils into inflamed airways, which lead to airway
wall remodeling through activated intracellular signaling
pathways. This study showed the enhanced secretion of IL-
8 and eotaxin-1 from endotoxin-exposed airway epithelial
cells and the increased induction of MIP-2 and CXCR2 in
lung tissues of OVA-challenged mice. MIP-2 is a functional
homolog of human IL-8 in mice. CXCR2 is the receptor
to IL-8 that is a powerful neutrophil chemotactic factor.
Also, kaempferol dampened epithelial secretion of IL-8
and eotaxin-1 and the induction of lung tissue CXCR2.
Additionally, kaempferol inhibited the CCR3 induction and
eotaxin-1 secretion enhanced by OVA challenge, indicating
that kaempferol may inhibit inflammatory cell infiltration
into the lesion sites of asthmatic inflammation. It should be
noted that the eotaxin-1 secretion may be secondary to IL-8
induction.
Several polyphenols are effective in allaying allergic
inflammation, resulting in symptom relief with the use
of allopathic medicines [22–25]. Soy isoflavones suppress
airway inflammation, hyperresponsiveness, and airway
remodeling in a murine model of allergic asthma [23].
Chrysin inhibits mast cell-derived allergic inflammatory
reactions by blocking production of histamine release
and proinflammatory cytokines [24]. Although diverse
undetermined molecular targets have been evidenced, the
molecular mechanisms underlying antiallergic actions of
polyphenols remain to be clarified [25, 26]. Our recent
study demonstrated that kaempferol suppressed eosinophil
infiltration and airway inflammation in allergic asthma
through disturbing NF-𝜅B signaling and eotaxin-1 secretion
[18]. Similarly, fisetin ameliorates asthmatic phenotypes
concomitant with suppression of NF-𝜅Ba n di t sd o w n s t r e a mEvidence-Based Complementary and Alternative Medicine 9
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chemokines [16]. In addition, casticin inhibits the eosinophil
migration and activity of chemokines and adhesion
molecules involved in the inflammatory process of asthma
by suppressing the NF-𝜅Bp a t h w a y[ 27]. Quercetin inhibits
IgE-mediated release of proinflammatory mediators from
human mast cells, possibly due to inhibition of intracellular
calcium influx and PKC𝜃 signaling [17]. However, the
possible action mechanism(s) of kaempferol antagonizing
the induction of inflammatory mediators responsible for
airway allergic inflammation are not still defined.
Exposure to LPS increases the severity of asthma, which
activates TLR signaling in regulation of Th2-driven airway
disease [7]. In this study, the epithelial induction of IL-
8 via TLR4 pathway stimulated eotaxin-1 expression asso-
ciated with asthmatic inflammation. Consistently in OVA-
challenged airway tissues MIP-2, CXCR2, and CCR3 were
simultaneously induced, indicative of possible airway activa-
tion of eotaxin-1 by IL-8. Most of ligands to CCR3 are asso-
ciatedwithasthma,andCCR3hasbecomeanappealingpos-
sibility in asthma treatment or therapy [21, 28]. Kaempferol10 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Time course response of STAT3 (a), suppression of STAT1/3 phosphorylation (b), and elevation of SOCS-3 expression (c) by
kaempferol in LPS-stimulated BEAS-2B cells. BEAS-2B cells were treated with 1–20𝜇M kaempferol in the absence and presence of 2𝜇g/mL
LPSfor8h.Forwesternblotanalysis,totalcellproteinextractswereimmunoblottedwithaprimaryantibodyagainstphosphorylatedSTAT1,
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represent quantitative densitometric results. Means without a common letter differ, 𝑃 < 0.05.
suppressed the induction of CXCR2 and CCR3 enhanced by
OVA challenge. Activated TLR4 leads to the promotion of
theinflammatorymechanismsincludingseveraldownstream
pathways of mitogen-activated protein kinasen, NF-𝜅B, and
JAK/STAT [10]. The current study investigated a Tyk-STAT-
responsive mechanism by which kaempferol disabled the IL-
8 responses in lung/airway epithelial cells through inflam-
matory TLR4 signaling pathway. The downregulation of IL-
8r e s p o n s eb yk a e m p f e r o li na i r w a ye p i t h e l i a lc e l l st h r o u g h
disturbing signaling pathways of Tyk2-STAT1/3 prevented
explosive asthmatic reactions due to eotaxin-1 activation.
The STAT proteins, cytokine-inducible transcription fac-
tors, are crucial for cytokine signaling and the acute phase
responses [11]. However, their role in mediating allergic
responses in asthma is not well defined. One investigation
showedthatairwayepithelialSTAT3wasresponsibleforaller-
gic inflammation by modulating Th2 cell recruitment and
effector function in a murine model of chronic asthma [29].
O u rs t u d yf o u n dt h a tS T A T 1a n dS T A T 3m i g h tb ei n v o l v e d
in endotoxin-induced airway epithelial IL-8 signaling and
subsequent eotaxin-1 activation. Likewise, the inhibition of
STAT3 and STAT5 ameliorated experimental asthma by
modulating lung CD11c(+) dendritic cells phenotype and
function[30]. Thus, targeting STAT1 and STAT3 may provide
the basis for a novel therapy for asthmatic inflammation
[31]. In the current study, kaempferol attenuated the STAT
activation through blocking the IL-8-Tyk2 pathway linked
to epithelial TLR4 signaling inflamed by LPS. Consistently,
kaempferol diminished the levels of STAT3 activated in
OVA-challenged mouse airway/lung tissues. The polyphenol
hesperidin-3
򸀠-O-methylether inhibits airway hyperrespon-
siveness in a murine model of asthma by decreasing the
number of inflammatory cells and OVA-specific IgE levels
in serum and BALF [32]. In addition, chlorogenic acidEvidence-Based Complementary and Alternative Medicine 11
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Figure 7: Immunohistochemical staining of phosphorylated STAT3 in lung tissues obtained from mice supplemented with 10–20mg/kg
kaempferol. Lung tissue sections were immunostained with a specific primary antibody against phosphorylated STAT3 and 3,3
򸀠-
diaminobenzidine-conjugated IgG. Counter staining was conducted with hematoxylin. Phosphorylated STAT3 was identified as brown
nuclearstaining(a)andquantifiedbyusinganopticalmicroscopesystem(b).Eachphotographisrepresentativeoffourmice.Magnification:
200-fold. Means without a common letter differ, 𝑃 < 0.05.
suppresses pulmonary eosinophilia, IgE production, and
Th2-type cytokine production in an OVA-induced allergic
asthma through inhibiting activation of STAT6 and JNK
[33]. On the other hand, SOCS proteins have an important
m e c h a n i s mf o rt h en e g a t i v er e g u l a t i o no ft h ec y t o k i n e - S T A T
pathway. Thus, SOCS proteins have been explored as targets
for therapeutic strategies in allergic asthma [12]. In this
study, the SOCS expression was reduced in LPS-exposed
airway epithelial cells, which was reversed by the kaempferol
treatment. Collectively, kaempferol boosted the inhibition
of the Tyk2-STAT1/3 pathway responsible for the cytokine
signaling of IL-8 and eventually regulated allergic asthma
phenotype.
In summary, this study investigated the potential of
kaempferol as targets for therapeutic strategies in endotoxin-
or cytokine-associated airway inflammation. Nontoxic
kaempferol suppressed LPS-induced production of IL-8
and subsequent induction of eotaxin-1. The IL-8 induction
of eotaxin-1 entailed the mediation of the TLR4 signaling
pathway that was blocked by kaempferol. Additionally, this
compound disturbed the IL-8-Tyk2-STAT1/3 signaling with
upregulationofSOCSinendotoxin-exposedairwayepithelial
cells. In the in vivo BALB/c mouse study, kaempferol
administration blocked the induction of MIP-2, CXCR2,
a n dC C R 3i na i rw a y / l u n gt i s s u e se l e v a t e db yO V Ac h a l l e n g e .
Moreover, kaempferol encumbered the OVA challenge-
inflamed Tyk2-STAT3 activation. Therefore, kaempferol was
effective in ameliorating allergic and inflammatory airway
diseases through disturbing Tyk-STAT-responsive signaling
p a t h w a yi n s t i g a t e db yI L - 8a d v e n ti nc e l l u l a ro ra n i m a l
models of allergic asthma.
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